These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20571993)

  • 1. Improvement of mutism in a catatonic schizophrenia case by add-on treatment with amantadine.
    Muneoka K; Shirayama Y; Kon K; Kawabe M; Goto M; Kimura S
    Pharmacopsychiatry; 2010 Jun; 43(4):151-2. PubMed ID: 20571993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mutism as permanent catatonic condition].
    Vater D
    Psychiatr Neurol Med Psychol (Leipz); 1976 Oct; 28(10):590-4. PubMed ID: 1019261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine and memantine in catatonic schizophrenia.
    Carroll BT; Thomas C; Jayanti K
    Ann Clin Psychiatry; 2006; 18(2):133-4. PubMed ID: 16754421
    [No Abstract]   [Full Text] [Related]  

  • 4. The differential diagnosis of mutism: a review and a report of three unusual cases.
    Akhtar S; Buckman J
    Dis Nerv Syst; 1977 Jul; 38(7):558-63. PubMed ID: 17518
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
    Iizuka J; Fischer R
    Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
    [No Abstract]   [Full Text] [Related]  

  • 7. Palliative treatment of tardive dyskinesia with combination of amantadine-neuroleptic administration.
    Allen RM
    Biol Psychiatry; 1982 Jun; 17(6):719-27. PubMed ID: 6179548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting therapy of schizophrenia.
    Rapisarda V; Bonomo V; Parisi R
    Adv Biochem Psychopharmacol; 1985; 40():25-8. PubMed ID: 4025038
    [No Abstract]   [Full Text] [Related]  

  • 9. [Present-day treatment of parkinsonism in the aged].
    Siegfried J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Successful use of amantadine in treatment of malignant neuroleptic syndrome].
    Blümlein G
    Psychiatr Prax; 1997 Sep; 24(5):257-8. PubMed ID: 9417555
    [No Abstract]   [Full Text] [Related]  

  • 11. Lorazepam and diazepam rapidly relieve catatonic signs in patients with schizophrenia.
    Huang TL
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):52-5. PubMed ID: 15679540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature.
    Kubo S; Iwatake A; Ebihara N; Murakami A; Hattori N
    Parkinsonism Relat Disord; 2008; 14(2):166-9. PubMed ID: 17509924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher than usual dosage of haloperidol: a pilot study in 'back ward' schizophrenics.
    Tanghe A; Declercq H
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):50-3. PubMed ID: 798191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of parkinsonism].
    Kaste M; Iivanainen M
    Duodecim; 1976; 92(10):514-25. PubMed ID: 949943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient].
    Ceballos-Baumann AO
    MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of amantadine and haloperidol in Huntington's chorea.
    Saran BM; Klein MS; Benay EM
    J Clin Psychiatry; 1980 Jun; 41(6):221. PubMed ID: 6445900
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
    Kamianov IM; Kupisk AG; Katsen IZ
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of Parkinson's disease. Practical criteria of treatment].
    Casacchia M; Carolei A; Zamponi A; Agnoli A; Fazio C
    Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360
    [No Abstract]   [Full Text] [Related]  

  • 19. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.